National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

hexamethylene bisacetamide
A hybrid polar-planar compound with potential antineoplastic activity that induces terminal differentiation, inhibits cell growth, and causes apoptosis in several tumor cell lines. Its precise mechanism of action is unknown. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:hexamethylenebisacetamide
hexamethylenediacetamide
Abbreviation:HMBA
Chemical structure names:
  • acetamide, N,N'-1, 6-hexanediylbis-
  • acetamide, N,N'-hexamethylenebis-
  • N, N'-diacetylhexamethylenediamine
  • N,N'-1,6-hexanediylbisacetamide
  • N,N'-hexamethylenebisacetamide



Previous:Herceptin, Herplex, Hexa-Betalin, Hexadrol, Hexalen
Next:hexamethylmelamine, Hexvix, HexvixR, hexyl 5-aminolevulinate, HibTITER

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov